Quick Answer
Prebiotic Gut Microbiome Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Background Gastrointestinal discomfort affects up to 70% of individuals with spinal cord injury (SCI), largely due to gut dysbiosis caused by altered transit time and reduced gastrointestinal motility from autonomic disruption.
Key Takeaways
- 01Background Gastrointestinal discomfort affects up to 70% of individuals with spinal cord injury (SCI), largely due to gut dysbiosis caused by altered transit time and reduced gastrointestinal motility from autonomic disruption. [Trunz J (2026)]
- 02Emerging evidence links prebiotics and probiotics to improved microbiome balance and reduced inflammation, yet data in SCI remain limited. [Trunz J (2026)]
- 03There is strong evidence of a correlation linking gut dysbiosis with reduced microbial diversity and a disruption in the balance of microbial communities, and inflammatory and metabolic disorders, including obesity and type 2 diabetes mellitus (T2DM) [,,]. [Alhaj Omar A. (2026)]
- 04Meta-analyses of clinical interventions corroborate the results of regular yogurt or kefir intake, showing significant decreases in fasting glucose, low-density lipoprotein (LDL) cholesterol, and systemic C-reactive protein (CRP) in dysbiosis-associated conditions, with effect sizes dependent on strain composition, dose, and host genotype [,,,]. [Alhaj Omar A. (2026)]
The current Migaku evidence database contains 3 reusable source documents for Prebiotic Gut Microbiome Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- Background Gastrointestinal discomfort affects up to 70% of individuals with spinal cord injury (SCI), largely due to gut dysbiosis caused by altered transit time and reduced gastrointestinal motility from autonomic disruption. [Trunz J (2026); evidence level 2]
- Emerging evidence links prebiotics and probiotics to improved microbiome balance and reduced inflammation, yet data in SCI remain limited. [Trunz J (2026); evidence level 2]
- There is strong evidence of a correlation linking gut dysbiosis with reduced microbial diversity and a disruption in the balance of microbial communities, and inflammatory and metabolic disorders, including obesity and type 2 diabetes mellitus (T2DM) [,,]. [Alhaj Omar A. (2026); evidence level 3]
- Meta-analyses of clinical interventions corroborate the results of regular yogurt or kefir intake, showing significant decreases in fasting glucose, low-density lipoprotein (LDL) cholesterol, and systemic C-reactive protein (CRP) in dysbiosis-associated conditions, with effect sizes dependent on strain composition, dose, and host genotype [,,,]. [Alhaj Omar A. (2026); evidence level 3]
- 9 35 36 9 9 37 9 35 38 39 9 35 Figure 1 Despite the compelling evidence for the DB components as GM modulators, three critical knowledge gaps remain, including dose–response characterization, long-term clinical efficacy, and elucidation of the mechanism’s pathway [,,]. [Alhaj Omar A. (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- Probiotic and Prebiotic Supplementation for Gastrointestinal Discomfort in Chronic Spinal Cord Injury (PRO-GIDSCI): A Randomized Controlled Crossover Trial Protocol.
- Dairy Bioactive Compounds as Precision Modulators of Gut Microbiota: From Molecular Mechanisms to Personalized Immunometabolic Health
- Multiomics insights into the effects of prebiotics on physical function and metabolism in adults with obesity and knee osteoarthritis.